Summary by Futu AI
Moderna, Inc. officer Shannon Thyme is set to sell 551 shares of the company's common stock on 09/09/2024, according to a recent filing. The shares to be sold were acquired on 09/06/2024 as part of a restricted stock vesting and are considered compensation for Thyme's role at Moderna. The transaction is part of Thyme's regular stock trading plan and follows a series of sales over the past three months, where a total of 6,773 shares were sold.